摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 2-(benzylamino)-3-phenylsulfanylpropanoate | 1011486-88-6

中文名称
——
中文别名
——
英文名称
Methyl 2-(benzylamino)-3-phenylsulfanylpropanoate
英文别名
——
Methyl 2-(benzylamino)-3-phenylsulfanylpropanoate化学式
CAS
1011486-88-6
化学式
C17H19NO2S
mdl
——
分子量
301.409
InChiKey
PBAUAIHDYKZMLL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    21
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    4-((2-iodophenyl)(methyl)amino)-4-oxobut-2(E)-enoic acid 、 Methyl 2-(benzylamino)-3-phenylsulfanylpropanoateN-甲基吗啉4-(4,6-二甲氧基三嗪-2-基)-4-甲基吗啉盐酸盐 作用下, 以 四氢呋喃 为溶剂, 以63%的产率得到
    参考文献:
    名称:
    A tandem radical cyclization approach to 3-(2-oxopyrrolidin-3-yl)indolin-2-ones, potential intermediates toward complex indole-heterocycles
    摘要:
    A series of substituted 3-(2-oxopyrrolidin-3-yl)indolin-2-one derivatives have been synthesized by tris(trimethylsilyl)silane (TTMSS) induced tandem radical cyclization as key step. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2007.11.194
点击查看最新优质反应信息

文献信息

  • Process for producing optically active cysteine derivatives
    申请人:Kaneka Corporation
    公开号:US20020169337A1
    公开(公告)日:2002-11-14
    A process for producing optically active cysteine derivatives with high optical purity and good quality which is economically advantageous and is high in productivity even on a commercial scale is provided. A process for producing an optically active cysteine derivative which comprises synthesizing a D-form or L-form optically active cysteine derivative of the general formula (2) shown below (R 1 represents an amino-protecting group of the urethane or acyl type, R 0 represents a hydrogen atom or, taken together with R 1 , an amino-protecting group, R 2 represents an alkyl, aryl or aralkyl group, R 3 represents a univalent organic group and * represents the position of an asymmetric carbon) by reacting the corresponding D-form or L-form optically active amino acid derivative of the general formula (1) shown below with an alcohol of the general formula (3) shown below and a strong acid and/or a thionyl halide and recovering the above cysteine derivative (2) from the reaction mixture, the procedural series from reaction to recovery being carried out under conditions such that the medium contacting the above optically active cysteine derivative (2) is within the range from acidic to weakly basic to thereby recover the above cysteine derivative (2) from the reaction mixture while suppressing the decomposition and racemization thereof. 1
    提供了一种生产高光学纯度和良好质量的光学活性半胱氨酸衍生物的工艺,该工艺在经济上具有优势,即使在商业规模上也具有高生产率。生产光学活性半胱氨酸衍生物的工艺包括通过将下面所示的一般式(1)的相应D型或L型光学活性氨基酸衍生物与下面所示的一般式(3)的醇和强酸和/或硫酰卤反应合成下面所示的一般式(2)的D型或L型光学活性半胱氨酸衍生物(其中R1表示脲或酰型氨基保护基,R0表示氢原子或与R1一起表示氨基保护基,R2表示烷基,芳基或芳基烷基,R3表示一价有机基团,*表示不对称碳的位置),并在其接触介质在酸性到微弱碱性范围内的条件下,从反应混合物中回收上述半胱氨酸衍生物(2),以抑制其分解和外消旋,从反应到回收的程序系列。
  • PROCESS FOR PRODUCING OPTICALLY ACTIVE CYSTEINE DERIVATIVES
    申请人:KANEKA CORPORATION
    公开号:EP1054000A1
    公开(公告)日:2000-11-22
    A process for producing optically active cysteine derivatives with high optical purity and good quality which is economically advantageous and is high in productivity even on a commercial scale is provided. A process for producing an optically active cysteine derivative which comprises synthesizing a D-form or L-form optically active cysteine derivative of the general formula (2) shown below (R1 represents an amino-protecting group of the urethane or acyl type, R0 represents a hydrogen atom or, taken together with R1, an amino-protecting group, R2 represents an alkyl, aryl or aralkyl group, R3 represents a univalent organic group and * represents the position of an asymmetric carbon) by reacting the corresponding D-form or L-form optically active amino acid derivative of the general formula (1) shown below with an alcohol of the general formula (3) shown below and a strong acid and/or a thionyl halide and recovering the above cysteine derivative (2) from the reaction mixture, the procedural series from reaction to recovery being carried out under conditions such that the medium contacting the above optically active cysteine derivative (2) is within the range from acidic to weakly basic to thereby recover the above cysteine derivative (2) from the reaction mixture while suppressing the decomposition and racemization thereof.
    本发明提供了一种生产光学纯度高、质量好的光学活性半胱氨酸衍生物的工艺,该工艺具有经济优势,即使在商业规模上也具有很高的生产率。 一种生产光学活性半胱氨酸衍生物的工艺,包括合成下图通式(2)的 D-型或 L-型光学活性半胱氨酸衍生物(R1 代表氨基保护基,属于氨基甲酸酯或酰基类型,R0 代表氢原子或与 R1 一起代表氨基保护基,R2 代表烷基、芳基或芳烷基、R3代表单价有机基团,*代表不对称碳的位置),将相应的下图所示通式(1)的 D-型或 L-型光学活性氨基酸衍生物与下图所示通式(3)的醇和强酸和/或硫代卤化物反应,并从反应混合物中回收上述半胱氨酸衍生物(2)、从反应到回收的一系列过程是在这样的条件下进行的:与上述具有光学活性的半胱氨酸衍生物(2)接触的介质处于从酸性到弱碱性的范围内,从而从反应混合物中回收上述半胱氨酸衍生物(2),同时抑制其分解和消旋化。
  • US6407281B1
    申请人:——
    公开号:US6407281B1
    公开(公告)日:2002-06-18
  • A tandem radical cyclization approach to 3-(2-oxopyrrolidin-3-yl)indolin-2-ones, potential intermediates toward complex indole-heterocycles
    作者:Marc Pudlo、Stéphane Gérard、Catherine Mirand、Janos Sapi
    DOI:10.1016/j.tetlet.2007.11.194
    日期:2008.2
    A series of substituted 3-(2-oxopyrrolidin-3-yl)indolin-2-one derivatives have been synthesized by tris(trimethylsilyl)silane (TTMSS) induced tandem radical cyclization as key step. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物